JO
GNMK

John Overdeck’s GenMark Diagnostics, Inc GNMK Stock Holding History

John Overdeck’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-232,002
Closed -$3.29M – 3927
2020
Q3 		$3.29M Sell
232,002
-101,441
-30% -$1.55M 0.01% 1017
2020
Q2 		$4.91M Buy
+333,443
New +$3.39M 0.02% 653
2020
Q1 		– Sell
-350,525
Closed -$1.69M – 4073
2019
Q4 		$1.69M Buy
350,525
+11,444
+3% +$63.1K 0.01% 1733
2019
Q3 		$2.06M Sell
339,081
-448
-0.1% -$2.8K 0.01% 1419
2019
Q2 		$2.2M Buy
339,529
+51,746
+18% +$365K 0.01% 1388
2019
Q1 		$2.04M Buy
287,783
+107,295
+59% +$707K 0.01% 1405
2018
Q4 		$877K Buy
180,488
+5,507
+3% +$28.7K ﹤0.01% 1732
2018
Q3 		$1.29M Sell
174,981
-10,008
-5% -$73.4K ﹤0.01% 1804
2018
Q2 		$1.18M Buy
184,989
+71,661
+63% +$474K ﹤0.01% 2029
2018
Q1 		$617K Sell
113,328
-322,559
-74% -$1.6M ﹤0.01% 2344
2017
Q4 		$1.82M Buy
435,887
+417,471
+2,267% +$2.51M 0.01% 1535
2017
Q3 		$177K Buy
18,416
+6,406
+53% +$66.6K ﹤0.01% 2609
2017
Q2 		$142K Sell
12,010
-85,774
-88% -$1.1M ﹤0.01% 2840
2017
Q1 		$1.25M Buy
97,784
+26,899
+38% +$324K ﹤0.01% 1766
2016
Q4 		$868K Sell
70,885
-100,552
-59% -$1.19M ﹤0.01% 2109
2016
Q3 		$2.02M Buy
+171,437
New +$1.65M 0.01% 1445
2015
Q3 		– Sell
-13,977
Closed -$127K – 2904
2015
Q2 		$127K Buy
+13,977
New +$141K ﹤0.01% 2690
2015
Q1 		– Sell
-68,206
Closed -$928K – 2949
2014
Q4 		$928K Buy
+68,206
New +$763K 0.01% 1407
2014
Q3 		– Sell
-14,090
Closed -$191K – 2165
2014
Q2 		$191K Buy
+14,090
New +$147K ﹤0.01% 1980
2014
Q1 		– Sell
-18,462
Closed -$246K – 2363
2013
Q4 		$246K Buy
+18,462
New +$224K ﹤0.01% 1949

Other funds holding GNMK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

John Overdeck's GNMK Position: Q4 2020 in Review

John Overdeck sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2020, closing a stake of 232,002 shares — an estimated $3.29M sold.

John Overdeck first reported a position in GNMK in Q4 2013 and held it in 20 quarters. The position peaked at $4.91M in Q2 2020. 151 funds tracked by Wall St. Rank hold GNMK as of Q4 2020.

  • John Overdeck reported no remaining GenMark Diagnostics, Inc position as of Q4 2020 after selling out during the quarter.
  • John Overdeck sold 232,002 GenMark Diagnostics, Inc shares in Q4 2020, an estimated $3.29M.
  • John Overdeck first reported a position in GenMark Diagnostics, Inc in Q4 2013 and held it in 20 quarters.
  • John Overdeck's GenMark Diagnostics, Inc position peaked at $4.91M in Q2 2020.
  • 151 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2020.

Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.